Linezolid use in hospitalized children

Pediatric Infectious Disease Journal

Volumn 33, Issue 1, 2014, Pages

  Hersh, Adam L ^a   Lee, Brian R ^b   Hedican, Erin B ^b   Herigon, Josh C ^b   Newland, Jason G ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S MERCY HOSPITAL   (United States)

Author keywords

Anti Infective Agents; Methicillin Resistant Staphylococcus Aureus; Oxazolidinones; Pediatrics

Indexed keywords

ANTIBIOTIC AGENT; LINEZOLID;

ADOLESCENT; CHILD; CHILDHOOD DISEASE; COHORT ANALYSIS; DRUG COST; FEMALE; HEMATOLOGY; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION SYSTEM; ONCOLOGY; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SCHOOL CHILD; TRANSPLANTATION;

ACETAMIDES; ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG PRESCRIPTIONS; FEMALE; HOSPITALIZATION; HUMANS; INFANT; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; OXAZOLIDINONES; STAPHYLOCOCCAL INFECTIONS;

EID: 84891544839     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000011     Document Type: Review

References (13)

1. Chiappini E, Conti C, Galli L, et al. Clinical efficacy and tolerability of linezolid in pediatric patients: A systematic review. Clin Ther. 2010;32: 66-88
2. Nambiar S, Rellosa N, Wassel RT, et al. Linezolid-associated peripheral and optic neuropathy in children. Pediatrics. 2011;127:e1528-e1532
3. Su E, Crowley K, Carcillo JA, et al. Linezolid and lactic acidosis: A role for lactate monitoring with long-term linezolid use in children. Pediatr Infect Dis J. 2011;30:804-806
4. Tavil B, Balci YI, Yildirim I, et al. Linezolid-induced reversible bicytopenia in a 4-year-old boy with methicillin-resistant Staphylococcus aureus bacteremia. Pediatr Hematol Oncol. 2008;25:67-71
5. Roberts SM, Freeman AF, Harrington SM, et al. Linezolid-resistant Staphylococcus aureus in two pediatric patients receiving low-dose linezolid therapy. Pediatr Infect Dis J. 2006;25:562-564
6. Sánchez García M, De la Torre MA, Morales G, et al. Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit. JAMA. 2010;303:2260-2264
7. Arias CA, Murray BE. The rise of the Enterococcus: Beyond Vancomycin resistance. Nat Rev Microbiol. 2012;10:266-278
8. Pakyz AL, Gurgle HE, Ibrahim OM, et al. Trends in antibacterial use in hospitalized pediatric patients in United States academic health centers. Infect Control Hosp Epidemiol. 2009;30:600-603
9. Simon A, Müllenborn E, Prelog M, et al. Use of linezolid in neonatal and pediatric inpatient facilities-results of a retrospective multicenter survey. Eur J Clin Microbiol Infect Dis. 2012;31:1435-1442
10. Herigon JC, Hersh AL, Gerber JS, Zaoutis TE, Newland JG. Antibiotic management of Staphylococcus aureus infections in US children's hospitals, 1999-2008. Pediatrics. 2010;125:e1294-1300
11. Gerber JS, Newland JG, Coffin SE, et al. Variability in antibiotic use at children's hospitals. Pediatrics. 2010;126:1067-1073
12. Hersh AL, Beekmann SE, Polgreen PM, et al. Antimicrobial stewardship programs in pediatrics. Infect Control Hosp Epidemiol. 2009;30:1211-1217
13. Santos RP, Prestidge CB, Brown ME, et al. Pharmacokinetics and pharmacodynamics of linezolid in children with cystic fibrosis. Pediatr Pulmonol. 2009;44:148-154